(Q47728732)

5 February 2018

title

Epidermal EGFR controls cutaneous host defense and prevents inflammation. (English)

1 reference

5 February 2018

author

Beate M. Lichtenberger

1

1 reference

5 February 2018

Colin R MacKenzie

10

1 reference

5 February 2018

Maria Sibilia

18

1 reference

5 February 2018

author name string

Peter A Gerber

2

1 reference

5 February 2018

Martin Holcmann

3

1 reference

5 February 2018

Bettina A Buhren

4

1 reference

5 February 2018

Nicole Amberg

5

1 reference

5 February 2018

Viktoria Smolle

6

1 reference

5 February 2018

Holger Schrumpf

7

1 reference

5 February 2018

Edwin Boelke

8

1 reference

5 February 2018

Parinaz Ansari

9

1 reference

5 February 2018

Andreas Wollenberg

11

1 reference

5 February 2018

Andreas Kislat

12

1 reference

5 February 2018

Jens W Fischer

13

1 reference

5 February 2018

Katharina Röck

14

1 reference

5 February 2018

Jürgen Harder

15

1 reference

5 February 2018

Jens M Schröder

16

1 reference

5 February 2018

Bernhard Homey

17

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 August 2013

1 reference

5 February 2018

Science Translational Medicine

published in

1 reference

5 February 2018

volume

5

1 reference

5 February 2018

issue

199

1 reference

5 February 2018

page(s)

199ra111

1 reference

5 February 2018

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The epidermal growth factor receptor: from development to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Mechanisms of cutaneous toxicities to EGFR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Staphylococcus aureus bacteremia secondary to severe erlotinib skin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

A peptide antibiotic from human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Antimicrobial skin peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The EGF receptor is required for efficient liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Images in clinical medicine. Erlotinib-induced hair alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

A new allele of the mouse hairless gene interferes with Hox/LacZ transgene regulation in hair follicle primordia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Skin toxicity caused by EGFR antagonists-an autoinflammatory condition triggered by deregulated IL-1 signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Mast cell stabilizer, ketotifen, prevents UV-induced wrinkle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The epidermal growth factor receptor system in skin repair and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Tumor immune escape by the loss of homeostatic chemokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Generation and validation of mice carrying a conditional allele of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Signalling pathways of the TNF superfamily: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

The Koebner-phenomenon in epidermal growth factor receptor inhibitor-induced cutaneous adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Human antimicrobial proteins effectors of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

RNase 7 contributes to the cutaneous defense against Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

Strain-dependent epithelial defects in mice lacking the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005886

10.1126/SCITRANSLMED.3005886

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

23966300

1 reference

5 February 2018